Divi's Lab.

Market Cap: Large Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE361B01024
NSEID: DIVISLAB
BSEID: 532488

INR

5,606.50

217.65 (4.04%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.13 lacs

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,606.50",
    "chg": 217.65,
    "chgp": "4.04%",
    "dir": 1,
    "prev_price": "5,388.85",
    "mcapval": "148,834.96 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE361B01024",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "23:00 PM",
    "bse_nse_vol": "6.13 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Surge in Open Interest for Divis Laboratories Signals Increased Market Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-12-7-surge-in-open-interest-amid-increased-trading-activity-1699335",
        "imagepath": "",
        "date": "2025-04-03 14:00:11",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 35,895 contracts, reflecting a rise of 4,046 contracts or 12.7% from the previous open interest of 31,849. This uptick in open interest coincides with a trading volume of 50,419 contracts, indicating heightened activity in the stock.\n\nIn terms of price performance, Divis Laboratories opened the day with a gain of 3.95%, reaching an intraday high of Rs 5,970, which represents a 5.37% increase. Despite this positive movement, the stock has underperformed its sector by 0.33%, although it has shown a consecutive gain over the last two days, yielding a total return of 4.03% during this period.\n\nThe stock's weighted average price suggests that more volume was traded closer to its low price, and it remains above its 20-day, 50-day, and 2..."
      },
      {
        "title": "Divis Laboratories Sees Significant Open Interest Surge Amid Active Trading Environment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-12-19-surge-in-open-interest-to-35730-contracts-1698239",
        "imagepath": "",
        "date": "2025-04-03 13:00:09",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 35,730 contracts, marking a rise of 3,881 contracts or 12.19% from the previous open interest of 31,849. This uptick coincides with a trading volume of 45,247 contracts, reflecting robust activity in the derivatives market.\n\nIn terms of price performance, Divis Laboratories opened with a notable gain of 3.95% and reached an intraday high of Rs 5,970, representing a 5.37% increase. The stock has shown a positive trend over the past two days, accumulating a total return of 4.33%. Currently, the stock's price is above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average.\n\nThe broader Pharmaceuticals & Drugs sector has also seen a gain of 2.23%, indicating a favorable environment..."
      },
      {
        "title": "Surge in Open Interest Signals Increased Market Engagement for Divis Laboratories",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-12-19-surge-in-open-interest-amid-increased-trading-activity-1696949",
        "imagepath": "",
        "date": "2025-04-03 12:00:11",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 35,730 contracts, reflecting a rise of 3,881 contracts or 12.19% from the previous open interest of 31,849. This uptick in open interest comes alongside a trading volume of 45,247 contracts, indicating heightened activity in the stock.\n\nIn terms of price performance, Divis Laboratories opened the day with a gain of 3.95%, reaching an intraday high of Rs 5,970, which represents a 5.37% increase. Over the past two days, the stock has shown a positive trend, accumulating returns of 3.65%. However, it has underperformed its sector, which has gained 2.51%, by 0.97%. \n\nThe stock's liquidity remains robust, with a delivery volume of 2.35 lakh shares on April 2, marking a 31.29% increase compared to the five-day average delivery volume. D..."
      },
      {
        "title": "Divis Laboratories Outperforms Sector Amid Broader Market Volatility and Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-stock-rises-4-54-outperforming-sensex-amid-strong-upward-trend-1693486",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/DivisLaboratori_priceRelatedfactors_883379.png",
        "date": "2025-04-03 09:35:18",
        "description": "Divis Laboratories has experienced notable stock performance, gaining 4.54% on April 3, 2025, and outperforming its sector. The stock has shown a strong upward trend, trading above key moving averages. Over the past year, it has delivered a substantial return compared to the broader market."
      },
      {
        "title": "Surge in Open Interest Signals Increased Activity for Divis Laboratories Stock",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-16-05-surge-in-open-interest-to-30791-contracts-1672750",
        "imagepath": "",
        "date": "2025-04-02 10:00:11",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 30,791 contracts, reflecting a rise of 4,258 contracts or 16.05% from the previous open interest of 26,533. This surge in open interest coincides with a trading volume of 26,428 contracts, indicating heightened activity in the stock.\n\nIn terms of price performance, Divis Laboratories has outperformed its sector by 0.95%, marking a positive shift after two consecutive days of decline. The stock is currently trading above its 200-day moving average but below its 5-day, 20-day, 50-day, and 100-day moving averages. Notably, the delivery volume on April 1 reached 197,000 shares, an increase of 10.46% compared to the 5-day average delivery volume, suggesting a rise in investor participation.\n\nWith a market capitalization of Rs 1,48,900 ..."
      },
      {
        "title": "Divis Laboratories Sees Surge in Open Interest Amid Market Activity and Price Fluctuations",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-12-52-surge-in-open-interest-amid-price-decline-1664079",
        "imagepath": "",
        "date": "2025-04-01 15:00:10",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest (OI) today. The latest OI stands at 29,855 contracts, reflecting a rise of 3,322 contracts or 12.52% from the previous OI of 26,533. This uptick in OI comes alongside a trading volume of 22,056 contracts, indicating heightened activity in the stock.\n\nIn terms of price performance, Divis Laboratories has underperformed its sector by 1.98%, with the stock recording a decline of 3.69% on the day. It has faced consecutive losses over the past two days, totaling a drop of 5.19%. The stock reached an intraday low of Rs 5,560.75, marking a decrease of 3.72% from the previous close. \n\nDespite these challenges, the stock remains above its 200-day moving average, although it is currently below its 5-day, 20-day, 50-day, and 100-day moving averages. The liquidity remains adequate fo..."
      },
      {
        "title": "Divis Laboratories Faces Short-Term Challenges Amid Broader Market Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-stock-declines-3-8-underperforming-sector-amid-broader-market-drop-1663051",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/4/DivisLaboratori_priceRelatedfactors_855326.png",
        "date": "2025-04-01 14:15:18",
        "description": "Divis Laboratories faced a decline on April 1, 2025, amid broader market challenges, trailing the Sensex. The stock has seen a cumulative loss over two days and is positioned above its 200-day moving average but below several shorter-term averages. Despite recent struggles, it has shown strong long-term growth."
      },
      {
        "title": "Divis Laboratories Exhibits Mixed Technical Trends Amid Strong Long-Term Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-technical-trend-shifts-from-bullish-to-mildly-bullish-amid-stock-price-decline-1656039",
        "imagepath": "",
        "date": "2025-04-01 08:01:32",
        "description": "Divis Laboratories, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5,753.90, showing a slight decline from the previous close of 5,855.20. Over the past year, Divis Laboratories has demonstrated significant resilience, achieving a remarkable 67.42% return, notably outperforming the Sensex, which recorded a return of 5.11% during the same period.\n\nIn terms of technical indicators, the company's weekly MACD is mildly bearish, while the monthly outlook remains bullish. The Relative Strength Index (RSI) shows no signal on both weekly and monthly charts, indicating a neutral momentum. The Bollinger Bands reflect a bearish trend on a weekly basis but are bullish monthly, suggesting mixed signals in price volatility. Moving averages indicate a mildly bullish trend daily, while the KST s..."
      },
      {
        "title": "Divis Laboratories Sees Significant Surge in Open Interest Amid Increased Trading Activity",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-18-13-surge-in-open-interest-to-45412-contracts-1608570",
        "imagepath": "",
        "date": "2025-03-26 15:00:21",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 45,412 contracts, reflecting a rise of 6,970 contracts or 18.13% from the previous open interest of 38,442. This surge coincides with a trading volume of 42,003 contracts, indicating heightened activity in the stock.\n\nIn terms of performance, Divis Laboratories has outperformed its sector by 0.88%, with a one-day return of 0.27%. The stock is currently trading above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average. Notably, there has been a decline in investor participation, with delivery volume dropping by 35.99% compared to the 5-day average.\n\nThe stock's liquidity remains robust, accommodating trade sizes of up to Rs 4 crore based on 2% of the 5-day average traded valu..."
      }
    ],
    "total": 121,
    "sid": "509760",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "08-Apr-2025",
      "details": "Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 is as attached.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2025",
      "details": "Intimation of trading window closure from April 01 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "31-Mar-2025",
      "details": "Intimation of cessation of Senior Management Personnel.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 02 Aug 24",
          "dt": "2024-08-02",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Surge in Open Interest for Divis Laboratories Signals Increased Market Activity

2025-04-03 14:00:11

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 35,895 contracts, reflecting a rise of 4,046 contracts or 12.7% from the previous open interest of 31,849. This uptick in open interest coincides with a trading volume of 50,419 contracts, indicating heightened activity in the stock. In terms of price performance, Divis Laboratories opened the day with a gain of 3.95%, reaching an intraday high of Rs 5,970, which represents a 5.37% increase. Despite this positive movement, the stock has underperformed its sector by 0.33%, although it has shown a consecutive gain over the last two days, yielding a total return of 4.03% during this period. The stock's weighted average price suggests that more volume was traded closer to its low price, and it remains above its 20-day, 50-day, and 2...

Divis Laboratories Sees Significant Open Interest Surge Amid Active Trading Environment

2025-04-03 13:00:09

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 35,730 contracts, marking a rise of 3,881 contracts or 12.19% from the previous open interest of 31,849. This uptick coincides with a trading volume of 45,247 contracts, reflecting robust activity in the derivatives market. In terms of price performance, Divis Laboratories opened with a notable gain of 3.95% and reached an intraday high of Rs 5,970, representing a 5.37% increase. The stock has shown a positive trend over the past two days, accumulating a total return of 4.33%. Currently, the stock's price is above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average. The broader Pharmaceuticals & Drugs sector has also seen a gain of 2.23%, indicating a favorable environment...

Surge in Open Interest Signals Increased Market Engagement for Divis Laboratories

2025-04-03 12:00:11

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 35,730 contracts, reflecting a rise of 3,881 contracts or 12.19% from the previous open interest of 31,849. This uptick in open interest comes alongside a trading volume of 45,247 contracts, indicating heightened activity in the stock. In terms of price performance, Divis Laboratories opened the day with a gain of 3.95%, reaching an intraday high of Rs 5,970, which represents a 5.37% increase. Over the past two days, the stock has shown a positive trend, accumulating returns of 3.65%. However, it has underperformed its sector, which has gained 2.51%, by 0.97%. The stock's liquidity remains robust, with a delivery volume of 2.35 lakh shares on April 2, marking a 31.29% increase compared to the five-day average delivery volume. D...

Divis Laboratories Outperforms Sector Amid Broader Market Volatility and Mixed Signals

2025-04-03 09:35:18

Divis Laboratories has experienced notable stock performance, gaining 4.54% on April 3, 2025, and outperforming its sector. The stock has shown a strong upward trend, trading above key moving averages. Over the past year, it has delivered a substantial return compared to the broader market.

Surge in Open Interest Signals Increased Activity for Divis Laboratories Stock

2025-04-02 10:00:11

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 30,791 contracts, reflecting a rise of 4,258 contracts or 16.05% from the previous open interest of 26,533. This surge in open interest coincides with a trading volume of 26,428 contracts, indicating heightened activity in the stock. In terms of price performance, Divis Laboratories has outperformed its sector by 0.95%, marking a positive shift after two consecutive days of decline. The stock is currently trading above its 200-day moving average but below its 5-day, 20-day, 50-day, and 100-day moving averages. Notably, the delivery volume on April 1 reached 197,000 shares, an increase of 10.46% compared to the 5-day average delivery volume, suggesting a rise in investor participation. With a market capitalization of Rs 1,48,900 ...

Divis Laboratories Sees Surge in Open Interest Amid Market Activity and Price Fluctuations

2025-04-01 15:00:10

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest (OI) today. The latest OI stands at 29,855 contracts, reflecting a rise of 3,322 contracts or 12.52% from the previous OI of 26,533. This uptick in OI comes alongside a trading volume of 22,056 contracts, indicating heightened activity in the stock. In terms of price performance, Divis Laboratories has underperformed its sector by 1.98%, with the stock recording a decline of 3.69% on the day. It has faced consecutive losses over the past two days, totaling a drop of 5.19%. The stock reached an intraday low of Rs 5,560.75, marking a decrease of 3.72% from the previous close. Despite these challenges, the stock remains above its 200-day moving average, although it is currently below its 5-day, 20-day, 50-day, and 100-day moving averages. The liquidity remains adequate fo...

Divis Laboratories Faces Short-Term Challenges Amid Broader Market Decline

2025-04-01 14:15:18

Divis Laboratories faced a decline on April 1, 2025, amid broader market challenges, trailing the Sensex. The stock has seen a cumulative loss over two days and is positioned above its 200-day moving average but below several shorter-term averages. Despite recent struggles, it has shown strong long-term growth.

Divis Laboratories Exhibits Mixed Technical Trends Amid Strong Long-Term Performance

2025-04-01 08:01:32

Divis Laboratories, a prominent player in the Pharmaceuticals & Drugs sector, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 5,753.90, showing a slight decline from the previous close of 5,855.20. Over the past year, Divis Laboratories has demonstrated significant resilience, achieving a remarkable 67.42% return, notably outperforming the Sensex, which recorded a return of 5.11% during the same period. In terms of technical indicators, the company's weekly MACD is mildly bearish, while the monthly outlook remains bullish. The Relative Strength Index (RSI) shows no signal on both weekly and monthly charts, indicating a neutral momentum. The Bollinger Bands reflect a bearish trend on a weekly basis but are bullish monthly, suggesting mixed signals in price volatility. Moving averages indicate a mildly bullish trend daily, while the KST s...

Divis Laboratories Sees Significant Surge in Open Interest Amid Increased Trading Activity

2025-03-26 15:00:21

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Drugs sector, has experienced a significant increase in open interest today. The latest open interest stands at 45,412 contracts, reflecting a rise of 6,970 contracts or 18.13% from the previous open interest of 38,442. This surge coincides with a trading volume of 42,003 contracts, indicating heightened activity in the stock. In terms of performance, Divis Laboratories has outperformed its sector by 0.88%, with a one-day return of 0.27%. The stock is currently trading above its 5-day, 20-day, 50-day, and 200-day moving averages, although it remains below the 100-day moving average. Notably, there has been a decline in investor participation, with delivery volume dropping by 35.99% compared to the 5-day average. The stock's liquidity remains robust, accommodating trade sizes of up to Rs 4 crore based on 2% of the 5-day average traded valu...

View All News